Allotment of scrip shares to Directors

RNS Number : 6912W
The MedicX Fund Limited
02 January 2014
 



 

 

Press Release

For immediate release                                                                                    

2 January 2014

 

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

 

Allotment of scrip shares to Directors of the Company

 

 

Members of the Company's Board of Directors elected to participate in the Company's scrip dividend scheme in respect of the December 2013 interim dividend for the quarter ended 30 September 2013, and accordingly acquired ordinary shares of no par value in the Company (the "Shares") as disclosed in the table below.  The Shares were sold out of treasury by the Company at the previously advised scrip calculation price of 80.55 pence per Share.

 


Shares Acquired

Total Shares held

Percentage Holding

David Staples (Chairman)

1,316

75,750

0.022%

Shelagh Mason

440

25,350

0.007%

John Hearle

430

24,739

0.007%

 

The Shares were acquired on 31 December 2013 and rank pari passu with the Company's existing ordinary shares.

 

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

 

End

 

For further information please contact:

 

MedicX Group                                                                     +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

 

Canaccord Genuity                                                              +44 (0) 20 7523 8000

Andrew Zychowski/Helen Goldsmith

 

Buchanan                                                                          +44 (0) 20 7466 5000

Charles Ryland/Sophie McNulty

 

MedicX Fund Limited                                                           +44 (0) 1481 723 450

David Staples, Chairman

 

 

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 123 properties.

 

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.  

 

The Company's website address is www.medicxfund.comNeither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFMGGMMMVGDZZ
UK 100

Latest directors dealings